To assess the analgesic effect of NK-1R antagonism, we exploited a bone pain mouse model involving intratibia injection of CML K562 cells that we have recently established (48). The gene discussed is TACR1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.